EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma

S. P. Angus; J. L. Oblinger; T. J. Stuhlmiller; P. A. Desouza; R. L. Beauchamp; L. Witt; X. Chen; J. T. Jordan; T. S. K. Gilbert; A. Stemmer Rachamimov; J. F. Gusella; S. R. Plotkin; S J. Haggarty; L-S Chang; G. L. Johnson; V. Ramesh

doi:10.1093/neuonc/noy046

EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma

S. P. Angus, J. L. Oblinger, T. J. Stuhlmiller, P. A. Desouza, R. L. Beauchamp, L. Witt, X. Chen, J. T. Jordan, T. S. K. Gilbert, A. Stemmer Rachamimov, J. F. Gusella, S. R. Plotkin, S J. Haggarty, L-S Chang, G. L. Johnson, V. Ramesh

Campbell University

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Neuro-Oncology
DOIs	https://doi.org/10.1093/neuonc/noy046
State	Published - Mar 21 2018

Disciplines

Pharmacy and Pharmaceutical Sciences

Access to Document

10.1093/neuonc/noy046License: Unspecified

https://pubmed.ncbi.nlm.nih.gov/29982664/

Cite this

Angus, S. P., Oblinger, J. L., Stuhlmiller, T. J., Desouza, P. A., Beauchamp, R. L., Witt, L., Chen, X., Jordan, J. T., Gilbert, T. S. K., Stemmer Rachamimov, A., Gusella, J. F., Plotkin, S. R., Haggarty, S. J., Chang, L.-S., Johnson, G. L., & Ramesh, V. (2018). EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma. Neuro-Oncology. https://doi.org/10.1093/neuonc/noy046

@article{cc6b6c7d85e4453385ca969d08a0100b,

title = "EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma",

author = "Angus, {S. P.} and Oblinger, {J. L.} and Stuhlmiller, {T. J.} and Desouza, {P. A.} and Beauchamp, {R. L.} and L. Witt and X. Chen and Jordan, {J. T.} and Gilbert, {T. S. K.} and {Stemmer Rachamimov}, A. and Gusella, {J. F.} and Plotkin, {S. R.} and Haggarty, {S J.} and L-S Chang and Johnson, {G. L.} and V. Ramesh",

year = "2018",

month = mar,

day = "21",

doi = "10.1093/neuonc/noy046",

language = "American English",

journal = "Neuro-Oncology",

}

TY - JOUR

T1 - EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma

AU - Angus, S. P.

AU - Oblinger, J. L.

AU - Stuhlmiller, T. J.

AU - Desouza, P. A.

AU - Beauchamp, R. L.

AU - Witt, L.

AU - Chen, X.

AU - Jordan, J. T.

AU - Gilbert, T. S. K.

AU - Stemmer Rachamimov, A.

AU - Gusella, J. F.

AU - Plotkin, S. R.

AU - Haggarty, S J.

AU - Chang, L-S

AU - Johnson, G. L.

AU - Ramesh, V.

PY - 2018/3/21

Y1 - 2018/3/21

UR - https://cufind.campbell.edu/pharmacy/2333

UR - https://pubmed.ncbi.nlm.nih.gov/29982664/

U2 - 10.1093/neuonc/noy046

DO - 10.1093/neuonc/noy046

M3 - Article

JO - Neuro-Oncology

JF - Neuro-Oncology

ER -

EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma

Disciplines

Access to Document

Other files and links

Cite this